
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) stock is trading higher on Tuesday, with a session volume of 45.12 million compared to the average volume of 1.171 million as per data from Benzinga Pro.
Olema Pharmaceuticals' stock surged over 200% in reaction to Roche Holdings AG's (OTC:RHHBY) phase 3 results from the lidERA Breast Cancer study of giredestrant in early-stage breast cancer.